Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Receives $40.42 Consensus PT from Brokerages
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the twenty-one brokerages that are covering the firm, Marketbeat.com reports. Nine research analysts have rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating on the […]
More Stories
The Global Economy Is Resilient, but the Benefits Are Becoming Increasingly Uneven
Global trade and international supply chains remain important drivers of economic activity. Image: Unsplash Economic Analysis The global economy has...
Upcoming Horror Movies in 2027: Release Dates and Cast
Fans of horror movies have plenty to look forward to in 2027. The year brings the return of major franchises...
Global Trade Could Accelerate the Green Economy, but Countries Need Stronger Cooperation
Solar energy is becoming an increasingly important part of global trade, investment and the transition towards a low-carbon economy. Image: TheUltimateGrass...
AI’s Growing Energy Appetite Is Creating a New Global Infrastructure Challenge
Data centres are becoming essential infrastructure for artificial intelligence, cloud computing and the global digital economy. Photo: Carl Lender, via...
How AI Can Help Businesses Reduce Website Development Costs
In 2023, McKinsey set up a lab and timed more than 40 of its own software developers on routine tasks,...
iPhone Overheating? Common Causes and Fixes
Apple designs its phones to work in different environments, including high air pressure, humidity, and hot and cold weather. When...
